MMP9 and anti-neutrophil cytoplasmic antibody-associated vasculitis: It was demonstrated by others that rituximab may decrease serum MMP-9 levels in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab [24].